Maen Abdelrahim, MD, PhD, Pharm D
The Methodist Hospital Research Institute
2
2
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Liangjun Zhu, Dr
Jiangu Cancer Hospital
Shared therapeutic areas:
Hannah Robinson, MD
University of Colorado, Denver
Shared therapeutic areas:
DEZHI LI
4th Affiliated Hospital, School of Medicine, Zhejiang University, China
Shared therapeutic areas:
Jean-Marc JML LIMACHER, Dr
Odimma Therapeutics
Shared therapeutic areas:
Yongkun Sun
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Shared therapeutic areas:
Dr Julie VINCENT
Centre Georges François Leclerc
Shared therapeutic areas:
Namrata Vijayvergia, MD
Fox Chase Cancer Center
Shared therapeutic areas:
Aung Naing, Md
M.D. Anderson Cancer Center
Shared therapeutic areas:
Salvatore Siena, MD
ASST Niguarda Hospital
Shared therapeutic areas:
Lauren Zimmaro, PhD
University of Colorado, Denver
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer
5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer
All 2 trials loaded